BIOQ - Bioqual, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Bioqual, Inc.

4 Research Court
Rockville, MD 20850
United States
240 404 7654

IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. David A. NewcomerChief Financial Officer123.78kN/A1961
Dr. Marisa St. Claire DVMVP - Primate Biology and Medicine103kN/A1965
Dr. Mark G. LewisChairman, CEO & PresN/AN/A1955
Mitch FranklinChief Operating OfficerN/AN/AN/A
Nancy A. MaddenVP of Admin. Operations & Biosafety OfficerN/AN/AN/A
Amounts are as of December 31, 2001 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Corporate Governance

Bioqual, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.